Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...

In the AXSANA/EUBREAST 3(R) study, researchers compared data about recurrence outcomes of more-invasive and less-invasive lymph node procedures.

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer PURPOSE: Axillary lymph node dissection ...

CAMBRIDGE, England--(BUSINESS WIRE)--A novel procedure could now spare breast cancer patients an invasive surgical procedure on their lymphatic system. At MD Anderson Cancer Center, doctors have ...

Women with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative breast cancer who have one positive sentinel node and no high-risk features can likely be spared ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Omission of completion axillary lymph node dissection did not increase recurrence among patients ...

Axillary reverse mapping (ARM) is an innovative surgical technique aimed at accurately delineating the lymphatic drainage of the upper extremity from that of the breast during axillary lymph node ...

SAN ANTONIO — Women with early breast cancer who have less extensive axillary surgery see no effect on their 10-year rates of locoregional recurrence and mortality than do those who have more ...

Effect of bevacizumab on the risk of chemotherapy-associated anemia in cancer patients: A meta-analysis. Background: Arm lymphedema and limb morbidity in patients going through axillary lymph node ...